Evaluating how feasible a new mobile phone application is for reducing sitting behaviour and improving blood sugar levels in Type 2 diabetes

The feasibility of mobile phone application, MyHealthAvatar, for reducing sitting time and improving mood and glucose control in Type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11167977

Enrollment

Registered

2017-07-06

Start date

2017-05-26

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Interventions

Randomisation will be completed using an online research randomiser tool (www.randomizer.org). Five blocks of four numbers will be generated to randomly assign each of the 20 participants to one of th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or female 2. Aged 18-65 years 3. Diagnosed with Type 2 diabetes in the last 4 years 4. In the first stage (single non-insulin blood glucose lowering therapy) or first intensification (dual treatment of metformin plus one other drug) of drug treatment or using a diet and exercise management strategy 5. Speak and read English 6. Body mass index (BMI) < 40 kg/m2

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes 2. Diseases or disorders related to diabetes (e.g. heart disease, damage to the retina at the back of the eye, kidney problems, and infections, ulcers or reduced ability to feel pain in feet) 3. Type 2 diabetes diagnosed more than 4 years ago 4. Pregnant 5. Severe obesity

Design outcomes

Primary

Measure	Time frame
1. Sedentary behaviour, measured using ActivPAL activity monitor at baseline and during the final week of the 8 week intervention 2. Oral glucose tolerance, measured using Oral Glucose Tolerance Test (OGTT) at baseline and post-intervention (8 weeks)	—

Secondary

Measure	Time frame
1. Physical activity, measured using ActivPAL activity monitor at baseline and during the final week of the 8 week intervention 2. Body fat, measured using bioelectrical impedance analysis and waist circumference at baseline and post-intervention (8 weeks) 3. Blood pressure, measured using using an automated oscillatory device at baseline and post-intervention (8 weeks) 4. Sedentary behaviour self-efficacy, measured using an adapted version of the Schwarzer and Renner (2007) Physical Exercise Self-Efficacy Scale at baseline and post-intervention (8 weeks) 5. Current mood, measured using the short Positive and Negative Affect Scale (PANAS) at baseline and post-intervention (8 weeks) 6. Psychological wellbeing, assessed using the National Wellbeing Measurement and the Warwick Edinburgh Mental Well-Being Scale (WEMWBS) at baseline and post-intervention (8 weeks)	—

Measure

Time frame

1. Physical activity, measured using ActivPAL activity monitor at baseline and during the final week of the 8 week intervention 2. Body fat, measured using bioelectrical impedance analysis and waist circumference at baseline and post-intervention (8 weeks) 3. Blood pressure, measured using using an automated oscillatory device at baseline and post-intervention (8 weeks) 4. Sedentary behaviour self-efficacy, measured using an adapted version of the Schwarzer and Renner (2007) Physical Exercise Self-Efficacy Scale at baseline and post-intervention (8 weeks) 5. Current mood, measured using the short Positive and Negative Affect Scale (PANAS) at baseline and post-intervention (8 weeks) 6. Psychological wellbeing, assessed using the National Wellbeing Measurement and the Warwick Edinburgh Mental Well-Being Scale (WEMWBS) at baseline and post-intervention (8 weeks)

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026